Relationship between the Expression of m6A Methyltransferase ZC3H13 Gene and the Clinical Features and Prognosis of Patients with Acute Myeloid Leukemia
10.19746/j.cnki.issn1009-2137.2025.06.002
- VernacularTitle:m6A甲基转移酶ZC3H13基因在急性髓系白血病中的表达与患者临床特征和预后的关系
- Author:
Jing XU
1
;
Fang-Gang REN
;
Zhuang-Hui HAO
;
Hong-Wei WANG
Author Information
1. 山西医科大学医学细胞生物与遗传学教研室;山西医科大学第二医院血液科实验室,山西太原 030001
- Publication Type:Journal Article
- Keywords:
acute myeloid leukemia;
ZC3H13;
clinical indicators;
prognosis
- From:
Journal of Experimental Hematology
2025;33(6):1558-1564
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the expression level of m6A methyltransferase ZC3H13 gene in primary acute myeloid leukemia(AML)and its relationship with clinical features and prognosis.Methods:A total of 131 newly diagnosed AML patients and 12 controls were enrolled from July 1,2018 to December 1,2021 in the Hematology Department of the Second Hospital of Shanxi Medical University.RT-qPCR technology was used to detect the expression level of ZC3H13 mRNA in bone marrow(BM)samples.A retrospective analysis was conducted to examine the correlation between ZC3H13 expression level and clinical indicators,gene mutations,and prognosis.Results:The expression level of ZC3H13 mRNA in primary AML patients was significantly higher than that in the control group(P＜0.001).The white blood cell count,proportion of BM blast cells,and relapse rate in the high ZC3H13 expression group were higher than those in the the low ZC3H13 expression group(all P＜0.05),while the Th/Ts ratio was lower(P＜0.01).Univariate survival analysis showed that patients with high expression of ZC3H13 had shorter median overall survival(OS)and disease-free survival(DFS)than those with low expression of ZC3H13(both P＜0.05).The results of multivariate Cox regression analysis showed that high-risk stratification(OS:HR=1.612,95％CI:1.151-2.257,P=0.005;DFS:HR=1.551,95％CI:1.031-2.335,P=0.035)and high ZC3H13 expression(OS:HR=1.756,95％CI:1.028-2.999,P=0.039;DFS:HR=1.935,95％CI:1.018-3.678,P=0.044)were both independent risk factors for OS and DFS in AML patients.Conclusion:The expression of ZC3H13 in AML patients may be related to tumor burden and immune function.Patients with high expression of ZC3H13 have poor prognosis,and high expression of ZC3H13 is an independent risk factor for the prognosis of AML patients.
